Tailoring cancer therapy – Validating basic science with the ‘supertrial’
To access this article, please choose from the options below
PII: S1574-7891(09)00109-4
doi:10.1016/j.molonc.2009.08.001
PII: S1574-7891(09)00109-4
doi:10.1016/j.molonc.2009.08.001